AstraZeneca approached Gilead about potential merger - Bloomberg News

  • 📰 Reuters
  • ⏱ Reading Time:
  • 2 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

South Africa News News

South Africa South Africa Latest News,South Africa South Africa Headlines

AstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc about a potential merger, Bloomberg News reported on Sunday, citing people familiar with the matter.

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease , during the outbreak of the coronavirus disease , in Oceanside, California, U.S., April 29, 2020.

Mike Blake/File Photo

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Under His eye...

Of course they did. THE ONLY ONES GETTING RICHER WHILE THE POOR BECOMES MORE IMPOVERISHED....

That's an interesting news, but it may be too early

Hope combined R&D could expedite coronavirus vaccine.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

2 billion doses of Oxford COVID-19 vaccine planned after Gates funding - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. It is a goodwill initiative, but a mistake. In fact, it may lead to finding vaccine later than expected! How? Well big pharma will push away alternatives that may work but they are not working on. Big money close to power always lead to corruption. I just hope that I am wrong. __MJDr It remains unclear whether the vaccine will work 🤨 So actual cost is $2.50/dose ($750M/300Mdoses). What will be the sale price then?
Source: BusinessInsider - 🏆 729. / 51 Read more »